- Report
- February 2024
- 250 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- October 2023
- 177 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- January 2024
- 147 Pages
Global
From €4097EUR$4,250USD£3,504GBP
- Report
- December 2023
- 199 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- February 2024
- 190 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- January 2024
- 145 Pages
Global
From €4097EUR$4,250USD£3,504GBP
- Report
- November 2022
- 129 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- July 2021
- 115 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2021
Global
From €3856EUR$4,000USD£3,298GBP
- Report
- April 2024
- 108 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- July 2023
- 118 Pages
Global
From €3500EUR$3,889USD£3,098GBP
The Diagnostic Enzyme market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect and measure the activity of enzymes in biological samples. These products are used to diagnose and monitor a variety of diseases, including metabolic disorders, cardiovascular diseases, and cancer. Diagnostic enzymes are also used to detect the presence of drugs and toxins in the body.
Diagnostic enzymes are available in a variety of formats, including liquid reagents, dry reagents, and kits. These products are used in a variety of settings, including hospitals, laboratories, and point-of-care settings.
Some companies in the Diagnostic Enzyme market include Abbott Laboratories, Bio-Rad Laboratories, Diazyme Laboratories, and Roche Diagnostics. Show Less Read more
